Publications by authors named "Jessica Rose Hervol"
J Infect Dis
October 2024
Article Synopsis
- A study was conducted using Medicare data to evaluate the effectiveness of a third COVID-19 vaccine dose among beneficiaries aged 65 and older during the Omicron variant surge.
- The results showed that 73.3% of the eligible individuals had received a third dose by March 2022, and it significantly reduced the risk of hospitalization and death, especially within the first 60 days.
- However, the added protection from the third dose declined after four months, highlighting the importance of ongoing vaccination efforts.
